Edition:
United States

Tibet Rhodiola Pharmaceutical Holding Co (600211.SS)

600211.SS on Shanghai Stock Exchange

31.98CNY
21 Aug 2018
Change (% chg)

¥1.26 (+4.10%)
Prev Close
¥30.72
Open
¥30.98
Day's High
¥32.00
Day's Low
¥30.71
Volume
721,803
Avg. Vol
1,342,871
52-wk High
¥47.00
52-wk Low
¥28.01

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 21 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 2 1,049.50 1,065.00 1,034.00 1,081.85
Year Ending Dec-19 2 1,330.50 1,411.00 1,250.00 1,267.36
Earnings (per share)
Year Ending Dec-18 2 1.50 1.54 1.46 1.47
Year Ending Dec-19 2 1.93 2.02 1.84 1.83

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 1,049.50 1,049.50 1,049.50 1,049.50 1,081.85
Year Ending Dec-19 1,330.50 1,330.50 1,330.50 1,330.50 1,267.36
Earnings (per share)
Year Ending Dec-18 1.50 1.50 1.50 1.50 1.47
Year Ending Dec-19 1.93 1.93 1.93 1.93 1.83

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0